Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inverness/Ostex International

This article was originally published in The Gray Sheet

Executive Summary

Women's health firm completes merger with osteoporosis test maker Ostex. Under the deal, each share of Ostex was exchanged for 0.126 shares of Inverness (1"The Gray Sheet" Sept. 16, 2002, In Brief)...

You may also be interested in...



Inverness Medical Innovations

Acquisition of osteoporosis product maker Ostex in stock deal worth roughly $37 mil. rounds out the women's healthcare provider's intellectual property portfolio, firm says in Sept. 9 conference call. Inverness cites the Ostex NTx assay's increasing acceptance for management and monitoring of osteoporosis treatments as a primary driver of the deal...

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018663

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel